The FDA asked Mayne and Mithra for additional bioequivalence data in comparison to Nuvaring. From what I have read, it looks like the FDA now have 2 months to respond again to Mayne, either with approval, additional questions or rejection. Anything is possible, but my strong assumption is that Mayne will have provided all of the necessary information and the FDA will approve. Time will tell.
- Forums
- ASX - By Stock
- MYX
- New Product Approvals
New Product Approvals, page-36
- There are more pages in this discussion • 190 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.27 |
Change
-0.100(1.36%) |
Mkt cap ! $618.4M |
Open | High | Low | Value | Volume |
$7.38 | $7.40 | $7.22 | $619.2K | 85.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5080 | $7.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.30 | 389 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5080 | 7.270 |
1 | 2753 | 7.250 |
1 | 539 | 7.240 |
1 | 539 | 7.230 |
1 | 539 | 7.210 |
Price($) | Vol. | No. |
---|---|---|
7.300 | 389 | 1 |
7.310 | 4039 | 2 |
7.320 | 539 | 1 |
7.330 | 539 | 1 |
7.340 | 539 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$7.27 |
  |
Change
-0.100 ( 0.69 %) |
|||
Open | High | Low | Volume | ||
$7.40 | $7.40 | $7.22 | 17278 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
MYX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online